|
"lane hy"的相关文件
显示项目 1-43 / 43 (共1页)
1
每页显示[10|25|50]项目
| 國家衛生研究院 |
2023-10 |
Adjunctive transcranial direct current stimulation (tDCS) plus sodium benzoate for the treatment of early-phase Alzheimer's disease: A randomized, double-blind, placebo-controlled trial
|
Lane, HY;Wang, SH;Lin, CH |
| 國家衛生研究院 |
2023-08 |
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline
|
Lane, HY;Wang, SH;Lin, CH |
| 高雄醫學大學 |
2014 |
以肌氨酸治療高功能自閉症孩童之臨床藥物試驗
|
楊品珍;藍先元;顏正芳;張震霖 ; Yang, P;Lane, HY;Yen, CF;CL , Chang |
| 國家衛生研究院 |
2013-10 |
Prognostic factors of radiofrequency ablation for hepatocellular carcinoma: A nationwide cohort study
|
Lee, TY;Ho, HJ;Kuo, KN;Lin, JT;Lane, HY;Wu, MS;Wu, CY |
| 中國醫藥大學 |
2011-12 |
The risk of temporomandibular disorder in patients with depression: a population-based cohort study.
|
Liao CH; Chang CS; Chang SN; Lane HY; Lyu SY; Morisky DE; Sung FC. |
| 國家衛生研究院 |
2006-11 |
Glutamate decarboxylase genes and alcoholism in Han Taiwanese men
|
Loh, EW; Lane, HY; Chen, CH; Chang, PS; Ku, LW; Wang, KHT; Cheng, ATA |
| 中國醫藥大學 |
2005 |
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
|
Lane, HY; Chang, YC; Liu, YC; Chiu, CC; Tsai, GE |
| 中國醫藥大學 |
2005 |
Expanded trinucleotide repeats in the TBP/SCA17 gene mapped to chromosome 6q27 are associated with schizophrenia
|
Chen, CM; Lane, HY; Wu, YR; Ro, LS; Chen, FL; Hung, WL; Hou, YT; Lin, CY; Huang, SY; Chen, IC; Soong, BW; Li, ML; Hsieh-Li, HM; Su, MT; Lee-Chen, GJ |
| 中國醫藥大學 |
2005 |
Expanded trinucleotide repeats in the TBP/SCA17 gene mapped to chromosome 6q27 are associated with schizophrenia
|
Chen, CM; Lane, HY; Wu, YR; Ro, LS; Chen, FL; Hung, WL; Hou, YT; Lin, CY; Huang, SY; Chen, IC; Soong, BW; Li, ML; Hsieh-Li, HM; Su, MT; Lee-Chen, GJ |
| 中國醫藥大學 |
2005 |
Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response
|
Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2005 |
A functional polymorphism in the promoter region of the tryptophan hydroxylase gene is associated with alcohol dependence in one aboriginal group in Taiwan
|
Sun, HS; Fann, CSJ; Lane, HY; Chang, YT; Chang, CJ; Liu, YL; Cheng, ATA |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2005 |
Regular-dose risperidone on QTc intervals
|
Chiu, CC; Chang, WH; Huang, MC; Chin, YW; Lane, HY |
| 中國醫藥大學 |
2005 |
Doparnine D-3 receptor Ser9GIy polymorphism and risperidone response
|
Lane, HY; Hsu, SK; Liu, YC; Chang, YC; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2005 |
Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics
|
Lane, HY; Lee, CC; Liu, YC; Chang, WH |
| 中國醫藥大學 |
2004 |
Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome
|
Su, KP; Lane, HY; Chuang, CL; Chen, KP; Shen, WW |
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2004 |
Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances
|
Lu, ML; Lane, HY; Lin, SK; Chen, KP; Chang, WH |
| 中國醫藥大學 |
2004 |
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
|
Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH |
| 中國醫藥大學 |
2004 |
Fine-tuning risperidone dosage for acutely exacerbated schizophrenia: clinical determinants
|
Lane, HY; Chang, YC; Chiu, CC; Lee, SH; Lin, CY; Chang, WH |
| 中國醫藥大學 |
2004 |
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
|
Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 中國醫藥大學 |
2004 |
Risperidone response and 5-HT6 receptor gene variance: genetic association analysis with adjustment for nongenetic confounders
|
Lane, HY; Lin, CC; Huang, CH; Chang, YC; Hsu, SK; Chang, WH |
| 中國醫藥大學 |
2004 |
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
|
Tsai, GC; Lane, HY; Yang, PC; Chong, MY; Lange, N |
| 中國醫藥大學 |
2004 |
Effects of dopamine D-2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function
|
Lane, HY; Lee, CC; Chang, YC; Lu, CT; Huang, CH; Chang, WH |
| 中國醫藥大學 |
2004 |
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia
|
Chiu, CC; Lane, HY; Huang, MC; Liu, HC; Jann, MW; Hon, YY; Chang, WH; Lu, ML |
| 中國醫藥大學 |
2003 |
Adjunctive fluvoxamine with clozapine
|
Lu, ML; Lane, HY |
| 中國醫藥大學 |
2003 |
QTc intervals are not prolonged in young healthy patients with recommended dosage of risperidone
|
Chiu, CC; Lane, HY; Huang, MC; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Effects of patient demographics, risperidone dosage, and clinical outcome on body weight in acutely exacerbated schizophrenia
|
Lane, HY; Chang, YC; Cheng, YC; Liu, GC; Lin, XR; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 中國醫藥大學 |
2003 |
Refining pharmacogenetic research in schizophrenia: Control for patient-related variables
|
Lane, HY; Chang, YC; Huang, CL; Chang, WH |
| 國立臺灣大學 |
2002-05 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: a pilot study.
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
| 中國醫藥大學 |
2002 |
Effects of olanzapine plasma concentrations on depressive symptoms in schizophrenia: A pilot study
|
Lane, HY; Guo, SC; Hwang, TJ; Chen, YS; Cheng, JJ; Lee, YC; Hong, CJ; Hwu, HG; Chang, WH |
| 中國醫藥大學 |
2002 |
Dosing strategies of clozapine-fluvoxamine cotreatment
|
Lu, ML; Lane, HY; Jann, MW; Chang, WH |
| 中國醫藥大學 |
2002 |
Fluvoxamine-clozapine interaction: Time-dependent?
|
Lu, ML; Lane, HY; Chang, WH |
| 中國醫藥大學 |
2002 |
Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene
|
Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH |
| 中國醫藥大學 |
2002 |
Influences of patient-related variables on risperidone efficacy for acutely exacerbated schizophrenia: Analyses with rigorous statistics
|
Lane, HY; Chang, YC; Chiu, CC; Chen, TT; Lee, SH; Chang, WH |
| 中國醫藥大學 |
2002 |
Association of risperidone treatment response with a polymorphism in the 5-HT2A receptor gene
|
Lane, HY; Chang, YC; Chiu, CC; Chen, ML; Hsieh, MH; Chang, WH |
| 國立臺灣大學 |
2001-05 |
A double-blinded study on efficacy and safety of olanzapine versus haloperidol in the treatment of schizophrenic patients.
|
Hong, CJ; Cheng, JJ; Hwang, TJ; Chen, YS; Guo, SC; Lane, HY; Lee, YC; Zhang, F; Chnag, WH; Tran, P; Hwu, HG |
| 臺北醫學大學 |
1999 |
Seizures after Discontinuation of Low-Dose Lorazepam From Originally Seizure-Free Clozapine Regimen: Combined Effects?
|
蘇冠賓; Lane HY; Su KP; Chang WH |
| 臺北醫學大學 |
1998 |
Elevated plasma clozapine concentrations after phenobarbital discontinuation
|
蘇冠賓; Lane HY; Su KP; Chang WH |
显示项目 1-43 / 43 (共1页)
1
每页显示[10|25|50]项目
|
